Insider Trading Activity Evolent Health, Inc (NYSE:EVH) – CEO Sold 16,300 shares of Stock

Insider Trading Activity For Evolent Health, Inc (NYSE:EVH)

Frank J. Williams , CEO of Evolent Health, Inc (NYSE:EVH) reportedly Sold 16,300 shares of the company’s stock at an average price of 23.73 for a total transaction amount of $386,799.00 SEC Form

Insider Trading History For Evolent Health, Inc (NYSE:EVH)

On 6/10/2015 Gary Piefer, Insider, bought 2,000 with an average share price of $17.00 per share and the total transaction amounting to $34,000.00.View SEC Filing

On 9/14/2016 Thomas Peterson III, COO, sold 72,827 with an average share price of $21.54 per share and the total transaction amounting to $1,568,693.58.View SEC Filing

On 9/14/2016 Seth Blackley, President, sold 167,672 with an average share price of $21.54 per share and the total transaction amounting to $3,611,654.88.View SEC Filing

On 9/14/2016 Nicholas Mcgrane, CFO, sold 21,205 with an average share price of $21.54 per share and the total transaction amounting to $456,755.70.View SEC Filing

On 9/14/2016 Jonathan Weinberg, General Counsel, sold 10,339 with an average share price of $21.54 per share and the total transaction amounting to $222,702.06.View SEC Filing

On 9/14/2016 Frank J Williams, CEO, sold 251,481 with an average share price of $21.54 per share and the total transaction amounting to $5,416,900.74.View SEC Filing

On 9/14/2016 Chad Pomeroy, Insider, sold 55,180 with an average share price of $21.54 per share and the total transaction amounting to $1,188,577.20.View SEC Filing

Analyst Ratings For Evolent Health, Inc (NYSE:EVH)
These are 11 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Evolent Health, Inc (NYSE:EVH) is Buy (Score: 3.08) with a consensus target price of $30.56 , a potential (26.79% upside)

Analyst Ratings History For Evolent Health, Inc (NYSE:EVH)

• On 8/5/2016 FBR & Co Boost Price Target of rating Outperform with a price target of $24.00 to $26.00
• On 9/30/2016 William Blair Reiterated Rating Outperform
• On 10/28/2016 J P Morgan Chase & Co Initiated Coverage of rating Overweight with a price target of $30.00
• On 1/13/2017 Wells Fargo & Company Upgraded rating Market Perform to Outperform
• On 2/3/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $31.00
• On 3/1/2017 Cantor Fitzgerald Reiterated Rating Buy with a price target of $26.00
• On 3/8/2017 Goldman Sachs Group Inc Upgraded rating Buy to Conviction-Buy with a price target of $30.00

Recent Trading Activity for Evolent Health, Inc (NYSE:EVH)
Shares of Evolent Health, Inc closed the previous trading session at 24.10 up +0.38 1.58% with 420,955 shares trading hands.